• Search
TheAHSNNetwork
  • Health and care reset
    • Health and care reset
    • Coronavirus (COVID-19)
  • Our work
    • National programmes
      • Blood Pressure Optimisation Programme
      • Polypharmacy Programme: getting the balance right
      • Eating disorders
      • ADHD diagnosis
      • Cardiovascular disease
      • Wound care
      • Insights prioritisation programme
    • Patient safety
    • Legacy programmes
    • New treatments and diagnostics (AAC)
    • Supporting innovators
    • Underpinning themes
      • Diversity in health innovation
      • Patient and public involvement
      • Sustainability and the environment
  • Latest
    • News
    • Blogs
    • Events
    • Newsletters
    • Podcasts
  • Resources
  • Atlas
  • About us
    • About us
    • Our people
    • Working in partnership
    • Careers
  • Contact us
Home / AHSN Network / AHSN Network welcomes NICE guidance on single lead ECG devices for detecting atrial fibrillation
Share
8 May 2019

AHSN Network welcomes NICE guidance on single lead ECG devices for detecting atrial fibrillation

The AHSN Network welcomes new diagnostics guidance from the National Institute for Health and Care Excellence (NICE) on the use of single lead ECG devices for detecting atrial fibrillation (AF), supporting its conclusion that further research is needed to better understand the full potential of these devices in the identification of AF, and subsequent stroke prevention.

Improving the detection and treatment of atrial fibrillation (AF) to prevent stroke is a priority for all 15 AHSNs. We are currently engaged in a national programme of work which spans the patient care pathway from detection through to treatment and monitoring.

The AHSN Network welcomes this recent publication from NICE into the use of lead-I ECG devices for detecting atrial fibrillation (AF) using single-time point testing in primary care. We support the conclusion that further research is required to better understand their full potential in the identification of AF, and subsequent AF stroke prevention.

Single lead (mobile) ECG devices were highlighted by Simon Stevens at the 2016 NHS Confed conference as an innovation that clinical commissioning groups (CCGs) should start commissioning to improve the detection of AF. As a result, NHS England identified funding to help stimulate the market and increase the uptake of such devices in primary and community care settings, with an evaluation aiming to answer the question, “can a system-wide procurement initiative improve the uptake of innovative technologies (mobile ECG technologies)?”

The AHSN Network was commissioned by NHS England to identify a range of suitable devices and distribute these across the country by working closely with primary and community care providers to select settings and clinical teams in which patients are likely to have an increased prevalence of AF, for example podiatry clinics, community teams for older people and mental health teams.

The project is being independently evaluated, which will inform the future use of the technology, in the context of current and future NICE guidance.  The evaluation will also provide insight into the wider drivers for the successful spread and adoption of digital innovation.

The full NICE guideline is available at www.nice.org.uk/guidance/dg35

GET THE LATEST HEALTH INNOVATION NEWS STRAIGHT TO YOUR INBOX

Sign up to our monthly newsletter, AHSN Network News, looking at the latest health innovation news, events, publications and opinion from across the AHSN Network.
Subscribe
AHSN Network News Feed


Getting the balance right: The AHSN Network launches new national programme to address problematic polypharmacy
News
Meet the Innovator: CPDmatch
Blog
TheAHSNNetwork
  • Contact us
  • Terms
  • Privacy
Copyright 2019 AHSN Network
  • Health and care reset
    • Health and care reset
    • Coronavirus (COVID-19)
  • Our work
    • National programmes
      • Blood Pressure Optimisation Programme
      • Polypharmacy Programme: getting the balance right
      • Eating disorders
      • ADHD diagnosis
      • Cardiovascular disease
      • Wound care
      • Insights prioritisation programme
    • Patient safety
    • Legacy programmes
    • New treatments and diagnostics (AAC)
    • Supporting innovators
    • Underpinning themes
      • Diversity in health innovation
      • Patient and public involvement
      • Sustainability and the environment
  • Latest
    • News
    • Blogs
    • Events
    • Newsletters
    • Podcasts
  • Resources
  • Atlas
  • About us
    • About us
    • Our people
    • Working in partnership
    • Careers
  • Contact us
We use cookies, just to track visits to our website, we store no personal details. Accept Cookies What are cookies?
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are as essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
SAVE & ACCEPT